SEC-sourced researchBeta
CLBT
Cellebrite DI Ltd.
Company comparison ↗
Data passport
- CIK
- 0001854587
- Exchange
- Nasdaq
- Business activity
- Services-Prepackaged Software · SIC 7372
- Financial inputs
- 6/6
- Filing date
- Nov 19, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 325,110,000.0000 | Mar 3, 2026 |
| December 2024 | 401,203,000.0000 | Mar 3, 2026 |
| December 2025 | 475,675,000.0000 | Mar 3, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 475,675,000.0000 | 78,326,000.0000 | 173,544,000.0000 | 938,852,000.0000 | 454,534,000.0000 | Mar 3, 2026 |
| December 2024 | 401,203,000.0000 | -283,007,000.0000 | 132,171,000.0000 | 690,567,000.0000 | 354,547,000.0000 | Mar 3, 2026 |
| December 2023 | 325,110,000.0000 | -81,100,000.0000 | 102,058,000.0000 | — | — | Mar 3, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
81/100
Profitability83
Growth69
Balance sheet52
Cash generation100
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $475.68M | Jan 1, 2025 – Dec 31, 2025 | Mar 3, 2026 | 20-F |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $401.2M | Jan 1, 2024 – Dec 31, 2024 | Mar 3, 2026 | 20-F |
| Net incomeNetIncomeLoss | $78.33M | Jan 1, 2025 – Dec 31, 2025 | Mar 3, 2026 | 20-F |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $173.54M | Jan 1, 2025 – Dec 31, 2025 | Mar 3, 2026 | 20-F |
| Total assetsAssets | $938.85M | Dec 31, 2025 | Mar 3, 2026 | 20-F |
| Total liabilitiesLiabilities | $454.53M | Dec 31, 2025 | Mar 3, 2026 | 20-F |
New filings
- 4CLBT · Cellebrite DI Ltd.Nov 19, 2026 · Other
- 4CLBT · Cellebrite DI Ltd.Nov 18, 2026 · Other
- 144CLBT · Cellebrite DI Ltd.Nov 17, 2026 · Other
- 6-KCLBT · Cellebrite DI Ltd.Nov 16, 2026 · Current event
- 4CLBT · Cellebrite DI Ltd.Nov 13, 2026 · Other
- 4CLBT · Cellebrite DI Ltd.Nov 12, 2026 · Other
- 6-KCLBT · Cellebrite DI Ltd.Nov 12, 2026 · Current event
- 144CLBT · Cellebrite DI Ltd.Nov 10, 2026 · Other
- 144CLBT · Cellebrite DI Ltd.Nov 10, 2026 · Other
- 144CLBT · Cellebrite DI Ltd.Nov 10, 2026 · Other
- 144CLBT · Cellebrite DI Ltd.Nov 10, 2026 · Other
- 144CLBT · Cellebrite DI Ltd.Nov 10, 2026 · Other
- 4CLBT · Cellebrite DI Ltd.Oct 19, 2026 · Other
- SCHEDULE 13GCLBT · Cellebrite DI Ltd.Oct 9, 2026 · Other
- 144CLBT · Cellebrite DI Ltd.Oct 7, 2026 · Other
- 4CLBT · Cellebrite DI Ltd.Sep 29, 2026 · Other
- 4CLBT · Cellebrite DI Ltd.Sep 29, 2026 · Other
- 4CLBT · Cellebrite DI Ltd.Sep 28, 2026 · Other
- 4CLBT · Cellebrite DI Ltd.Sep 25, 2026 · Other
- 6-KCLBT · Cellebrite DI Ltd.Sep 24, 2026 · Current event